Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $13.79M in the twelve months ending March 31, 2024, down -1.90% year-over-year. Revenue in the quarter ending March 31, 2024 was $986.00K, a -63.79% decrease year-over-year. In the year 2023, Aligos Therapeutics had annual revenue of $15.53M with 11.66% growth.

• Revenue (ttm): $13.79M
• Revenue Growth: -1.90%
• P/S Ratio: 3.74
• Revenue / Employee: $208,970
• Employees: 66
• Market Cap: 51.63M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	15.53M	1.62M	11.66%
Dec 31, 2022	13.91M	9.55M	219.04%
Dec 31, 2021	4.36M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.